Skip to content

Clinical trials

Phase 2 Neoplasms trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 2 Country / region: Portugal Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20071
20081
20152
20181
20193
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
MedImmune LLC2
Actuate Therapeutics Inc.1
AstraZeneca1
Bayer1
Bristol-Myers Squibb1
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Merck KGaA, Darmstadt, Germany1
Sanofi1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms12
Carcinoma, Non-Small-Cell Lung4
Breast Neoplasms3
Colorectal Neoplasms2
Lung Neoplasms2
Neoplasm Metastasis2
Ovarian Neoplasms2
Sarcoma2
Biliary Tract Neoplasms1
Bone Marrow Diseases1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.